Fanconi Anemia Complementation Group S C4554406
A rare genetic disorder in the Fanconi anemia DNA repair pathway. It may lead to bone marrow problems and increased cancer susceptibility. Care includes regular blood monitoring and transplant when needed.
Key facts at a glance
- ICD-10
- D61.03
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Pallor
(hematologic)Prolonged bleeding after cuts
(hematologic)Gingival bleeding
(hematologic)Renal anomalies
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Allogeneic Hematopoietic Stem Cell Transplantation
Bone marrow transplant remains the only curative option for hematologic manifestations in Fanconi anemia complementation group S. Specialized protocols accounting for underlying DNA repair defects are essential.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Growth Factors and Androgen Therapy
Granulocyte colony-stimulating factor may be used for neutropenia, while androgens can stimulate erythroid and megakaryocyte production. Combination approaches may be employed based on individual patient response.
Additional treatment options
Comprehensive Cancer Surveillance
Enhanced surveillance for solid tumors and hematologic malignancies given elevated cancer risk. Includes regular imaging, endoscopy, and tumor marker assessment as indicated by clinical guidelines.
monitoringPsychosocial Support Services
Mental health support addressing chronic illness burden, family stress, and quality of life concerns. Includes counseling, support groups, and transition planning for adolescent and young adult patients.
psychologicalInfection Prevention Strategies
Implementation of infection control measures including prophylactic antibiotics, meticulous hygiene, and avoidance of crowd exposure during periods of neutropenia. Education for patient and family on infection recognition.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Fanconi Anemia Complementation Group S C4554406?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Fanconi Anemia Complementation Group S C4554406. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy